Sign inJoin waitlistJoin the waitlist

Parameswaran Hari

Physician · Medical College of Wisconsin

Credentials: · · · ·

History

Medical College of Wisconsin
Present

Medical Oncology
1995–1997
Internal Medicine
1992–1995
Doctor of Medicine
1988–1992

Research

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a…
The Lancet · 2021 · 1,514 citations
Lenalidomide after stem-cell transplantation for multiple myeloma
New England Journal of Medicine · 2012 · 909 citations
Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study
The Lancet Oncology · 2020 · 657 citations

Anita D'Souza
91 papers · 1 as a fellow
Binod Dhakal
80 papers
Marcelo Pasquini
70 papers
Saurabh Chhabra
70 papers
Hillard Lazarus
62 papers
David Vesole
48 papers
CF
Cesar Freytes
46 papers
TF
Timothy Fenske
45 papers
Shaji Kumar
38 papers
Luciano Costa
34 papers
Wael Saber
34 papers
Saad Usmani
29 papers

Grants

BMT Core- Medical College of Wisconsin
National Heart, Lung, and Blood Institute · UG1
Contact PI · $720.7K · Medical College of Wisconsin
2017–2024
A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies
National Heart, Lung, and Blood Institute · R01
PI · $3.4M · Medical College of Wisconsin
2019–2024

Clinical trials

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration
Principal investigator · Active not recruiting · Phase 3
SWOG Cancer Research Network
2019–2040
Pharmacokinetic Study of Propylene Glycol-Free Melphalan HCl for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation
Principal investigator · Completed · Phase 2
Medical College of Wisconsin
2016–2017
Study of Bendamustine and IXAZOMIB (MLN9708) Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma
Principal investigator · Completed · Phase 1, Phase 2
Parameswaran Hari
2015–2020
Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)
Principal investigator · Completed · Phase 2
National Heart, Lung, and Blood Institute (NHLBI)
2005–2013